Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Yasheng Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Lanzhou, China, primarily focused on the development and production of licorice-derived medicinal products and traditional Chinese medicines (TCM). As a subsidiary of the Gansu Yasheng Industrial Group, the company leverages one of the largest licorice cultivation bases in the country to manufacture active pharmaceutical ingredients (APIs) such as glycyrrhizic acid and finished products like Compound Glycyrrhiza Oral Solution. Its operations span the entire value chain from herbal cultivation and extraction to the production of oral liquids, tablets, and granules. The company's products are widely used in the treatment of respiratory conditions, liver diseases, and inflammatory disorders. Gansu Yasheng Pharmaceutical is recognized as a key high-tech enterprise in Gansu Province, contributing significantly to the industrialization of regional medicinal resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Yasheng Pharmaceutical.